MRI contrast agent developer Advanced Magnetics of Cambridge, MA, has entered into definitive agreements with institutional investors to buy 1.47 million shares of its common stock. The proceeds of the sale, which will close in the next two business days, are expected to raise gross proceeds of $10 million, the company said.
By AuntMinnie.com staff writersJuly 3, 2003
Related Reading
Advanced Magnetics falls into red in Q1, January 16, 2003
MRI agent detects lymph node disease in prostate and renal cancers, December 4, 2002
Advanced Magnetics revenues decline, November 25, 2002
NCI to study Advanced Magnetics agents, October 1, 2002
Contrast agents herald new progress in MR lymphography, August 9, 2002
Copyright © 2003 AuntMinnie.com